Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations

Chromosomal aberrations are frequently associated with therapy‐related myelodysplastic syndromes and acute myelogenous leukemia (t‐MDS/AML) and are thought to result from exposure to genotoxic drugs, including alkylating agents and DNA topoisomerase II poisons. The NUP98 gene on chromosome band 11p1...

Full description

Saved in:
Bibliographic Details
Published inGenes chromosomes & cancer Vol. 29; no. 2; pp. 96 - 105
Main Authors Ahuja, Harish G., Felix, Carolyn A., Aplan, Peter D.
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 01.10.2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Chromosomal aberrations are frequently associated with therapy‐related myelodysplastic syndromes and acute myelogenous leukemia (t‐MDS/AML) and are thought to result from exposure to genotoxic drugs, including alkylating agents and DNA topoisomerase II poisons. The NUP98 gene on chromosome band 11p15 is involved in several different chromosomal aberrations that have been associated with t‐MDS/AML. We have cloned the translocation breakpoints from two cases of t‐MDS harboring a t(11;20)(p15;q11). Sequence analysis of the breakpoints from both cases revealed almost perfectly balanced translocations between NUP98 and TOP1. There were no known recombinogenic sequences identified at or near the breakpoints. However, four bp microduplications present at the translocation crossover points suggested that these translocations may have been initiated by 4 bp staggered double‐stranded DNA breaks, which are known to be associated with the action of topoisomerase II. Given the history of patient exposure to topoisomerase II poisons, and the fact that these drugs stabilize staggered breaks with a 4 bp overhang, it seems possible that drug‐induced topoisomerase II cleavage and subunit exchange was involved in these translocations. These results suggest that NUP98 is a recurrent target for therapy‐related malignancies induced by multiagent chemotherapy, and suggest a role for DNA topoisomerase II poisons in the generation of these translocations. Published 2000 Wiley‐Liss, Inc.
Bibliography:NIH - No. CA16056; No. CA73773; No. CA66140; No. CA77683; No. CA80175
istex:21405F2F1AADA0D02888DE97B7EFB7F20169BE3D
ArticleID:GCC1013
This article is a US Government work and, as such, is in the public domain in the United States of America.
ark:/67375/WNG-LDD2GPVH-0
Leukemia Society of America
ISSN:1045-2257
1098-2264
DOI:10.1002/1098-2264(2000)9999:9999<::AID-GCC1013>3.0.CO;2-T